1. Home
  2. MRTN vs MPLT Comparison

MRTN vs MPLT Comparison

Compare MRTN & MPLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Marten Transport Ltd.

MRTN

Marten Transport Ltd.

HOLD

Current Price

$17.34

Market Cap

1.4B

Sector

Industrials

ML Signal

HOLD

MPLT

MapLight Therapeutics Inc.

HOLD

Current Price

$27.14

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MRTN
MPLT
Founded
1946
2018
Country
United States
United States
Employees
N/A
133
Industry
Trucking Freight/Courier Services
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.3B
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
MRTN
MPLT
Price
$17.34
$27.14
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$32.67
AVG Volume (30 Days)
790.3K
272.0K
Earning Date
04-23-2026
05-28-2026
Dividend Yield
1.61%
N/A
EPS Growth
N/A
N/A
EPS
0.02
N/A
Revenue
$1,131,455,000.00
N/A
Revenue This Year
$2.23
N/A
Revenue Next Year
$8.59
N/A
P/E Ratio
$888.50
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.35
$12.24
52 Week High
$18.48
$33.28

Technical Indicators

Market Signals
Indicator
MRTN
MPLT
Relative Strength Index (RSI) 55.69 45.70
Support Level $14.31 $26.07
Resistance Level $18.48 $31.69
Average True Range (ATR) 0.50 2.43
MACD -0.10 -0.26
Stochastic Oscillator 25.16 26.24

Price Performance

Historical Comparison
MRTN
MPLT

About MRTN Marten Transport Ltd.

Marten Transport Ltd is a temperature-sensitive and dry truckload carrier in the United States. The company specializes in transporting and distributing food and other consumer packaged goods that require a temperature-controlled or insulated environment. The company operates through four segments: Truckload, Dedicated, Intermodal, and Brokerage, generating the majority of its revenue from the Truckload segment. The Truckload segment offers a mix of regional short-haul and medium- to long-haul full-load transportation services transporting food and other consumer packaged goods.

About MPLT MapLight Therapeutics Inc.

MapLight Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing treatments for central nervous system disorders. Its discovery platform identifies neural circuits causally linked to disease and targets them for therapeutic modulation, aiming to improve efficacy, safety, tolerability, and ease of use. The company was founded by leaders in psychiatry and neuroscience research to address the lack of circuit-specific pharmacotherapies. Its product candidate, ML-007C-MA, is a fixed-dose combination of an M1/M4 muscarinic agonist and a peripherally acting anticholinergic, being developed for schizophrenia and Alzheimer's disease psychosis, designed to activate central receptors while mitigating peripheral side effects.

Share on Social Networks: